DCF — PAM SPC HOSP OF SAN ANTONIO MED CTR
Enterprise Value: $5.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$5.5M
Enterprise Value
$0.8M
PV of Cash Flows
$4.7M
PV of Terminal Value
$7.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $32.4M | $1.3M | 4.0% | $-0.2M | $-0.2M |
| Year 2 | $33.4M | $1.7M | 5.0% | $0.1M | $0.1M |
| Year 3 | $34.4M | $2.1M | 6.0% | $0.3M | $0.2M |
| Year 4 | $35.5M | $2.3M | 7.0% | $0.5M | $0.3M |
| Year 5 | $36.5M | $2.5M | 7.0% | $0.6M | $0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $5.5M. Terminal value accounts for 85% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$31.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.035951135333344784
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5